Animal models of mucosal Candida infection

FEMS Microbiology Letters

Volumn 283, Issue 2, 2008, Pages 129-139

  Naglik, Julian R ^a   Fidel Jr , Paul L ^b   Odds, Frank C ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Animal; Epithelium; Model; Mucosal; Oral; Vaginal

Indexed keywords

ADAPTIVE IMMUNITY; CANDIDA ALBICANS; CELLULAR IMMUNITY; DISEASE MODEL; FUNGAL VIRULENCE; GASTROINTESTINAL INFECTION; HOST RESISTANCE; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; THRUSH; VAGINA CANDIDIASIS;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CANDIDIASIS, VULVOVAGINAL; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL DISEASES; HOST-PATHOGEN INTERACTIONS; INTESTINAL MUCOSA; RODENTIA; T-LYMPHOCYTES; VIRULENCE FACTORS;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; RODENTIA;

EID: 43549108302     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2008.01160.x     Document Type: Short Survey

References (80)

1. Algin C, Sahin A, Kiraz N, Sahinturk V Ihtiyar E (2005) Effectiveness of bombesin and Saccharomyces boulardii against the translocation of Candida albicans in the digestive tract in immunosuppressed rats. Surg Today 35 : 869 873.
2. Balish E, Filutowicz H Oberley TD (1990) Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect Immun 58 : 107 113.
3. Brown AJP, Odds FC Gow NAR (2007) Infection-related gene expression in Candida albicans. Curr Opin Microbiol 10 : 307 313.
4. Buurman ET, Westwater C, Hube B, Brown AJ, Odds FC Gow NAR (1998) Molecular analysis of CaMnt1p, a mannosyl transferase important for adhesion and virulence of Candida albicans. Proc Natl Acad Sci USA 95 : 7670 7675.
5. Calderon L, Williams R, Martinez M, Clemons KV Stevens DA (2003) Genetic susceptibility to vaginal candidiasis. Med Mycol 41 : 143 147.
6. Calera JA, Zhao XJ, De Bernardis F, Sheridan M Calderone R (1999) Avirulence of Candida albicans CaHK1 mutants in a murine model of hematogenously disseminated candidiasis. Infect Immun 67 : 4280 4284.
7. Cantorna MT Balish E (1990) Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 58 : 1093 1100.
8. Capilla J, Clemons KV Stevens DA (2007) Animal models: an important tool in mycology. Med Mycol 45 : 657 684.
9. Cassone A, De BF Santoni G (2007) Anticandidal immunity and vaginitis: novel opportunities for immune intervention. Infect Immun 75 : 4675 4686.
10. Chamilos G, Lionakis MS, Lewis RE Kontoyiannis DP (2007) Role of mini-host models in the study of medically important fungi. Lancet Infect Dis 7 : 42 55.
11. Cheng S, Clancy CJ, Checkley MA, Zhang Z, Wozniak KL, Seshan KR, Jia HY, Fidel P Jr., Cole G Nguyen MH (2005) The role of Candida albicans NOT5 in virulence depends upon diverse host factors in vivo. Infect Immun 73 : 7190 7197.
12. Chiang LY, Sheppard DC, Bruno VM, Mitchell AP, Edwards JE Jr. Filler SG (2007) Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasis. Cell Microbiol 9 : 233 245.
13. Clemons KV, Spearow JL, Parmar R, Espiritu M Stevens DA (2004) Genetic susceptibility of mice to Candida albicans vaginitis correlates with host estrogen sensitivity. Infect Immun 72 : 4878 4880.
14. Clemons KV, Gonzalez GM, Singh G, Imai J, Espiritu M, Parmar R Stevens DA (2006) Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs. Antimicrob Agents Chemother 50 : 2650 2657.
15. Cole AM (2006) Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol 306 : 199 230.
16. Cole MF, Bowen WH, Zhao XJ Cihlar RL (1995) Avirulence of Candida albicans auxotrophic mutants in a rat model of oropharyngeal candidiasis. FEMS Microbiol Lett 126 : 177 180.
17. De Bernardis F, Muhlschlegel FA, Cassone A Fonzi WA (1998) The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect Immun 66 : 3317 3325.
18. De Bernardis F, Arancia S, Morelli L, Hube B, Sanglard D, Schafer W Cassone A (1999) Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J Infect Dis 179 : 201 208.
19. De Bernardis F, Lucciarini R, Boccanera M, Amantini C, Arancia S, Morrone S, Mosca M, Cassone A Santoni G (2006) Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis. Infect Immun 74 : 4282 4294.
20. de Repentigny L (2004) Animal models in the analysis of Candida host-pathogen interactions. Curr Opin Microbiol 7 : 324 329.
21. Deslauriers N, Coulombe C, Carre B Goulet JP (1995) Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of Candida albicans. FEMS Immunol Med Microbiol 11 : 45 55.
22. Dolan JW, Bell AC, Hube B, Schaller M, Warner TF Balish E (2004) Candida albicans PLD I activity is required for full virulence. Med Mycol 42 : 439 447.
23. Dongari-Bagtzoglou A Fidel PL Jr. (2005) The host cytokine responses and protective immunity in oropharyngeal candidiasis. J Dent Res 84 : 966 977.
24. Dongari-Bagtzoglou A Kashleva H (2006) Development of a novel three-dimensional in vitro model of oral Candida infection. Microbial Pathogen 40 : 271 278.
25. Elahi S, Pang G, Clancy R Ashman RB (2000) Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect Immun 68 : 5771 5777.
26. Elahi S, Pang G, Ashman RB Clancy R (2001) Nitric oxide-enhanced resistance to oral candidiasis. Immunology 104 : 447 454.
27. Farah CS, Elahi S, Drysdale K, Pang G, Gotjamanos T, Seymour GJ, Clancy RL Ashman RB (2002a) Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis. Infect Immun 70 : 724 731.
28. Farah CS, Gotjamanos T, Seymour GJ Ashman RB (2002b) Cytokines in the oral mucosa of mice infected with Candida albicans. Oral Microbiol Immunol 17 : 375 378.
29. Farah CS, Hu Y, Riminton S Ashman RB (2006) Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting. Oral Microbiol Immunol 21 : 252 255.
30. Fidel PL Jr. (2006) Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Adv Dent Res 19 : 80 84.
31. Fidel PL (2007) History and update on host defense against vaginal candidiasis. Am J Reprod Immunol 57 : 2 12.
32. Fidel PL Jr., Barousse M, Espinosa T, Camaratti C, Ficarra M, Martin DH, Quayle AJ Dunlap K (2004a) A live intravaginal Candida challenge in humans reveals new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 72 : 2939 2946.
33. Fidel PL Jr., Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, Quayle AJ Dunlap K (2004b) An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 72 : 2939 2946.
34. Fidel PLJ Finkel-Jimenez B (2006) Site-specific host immunity to fungi: lessons learned from Candida albicans applied to other fungi. Molecular Principles of Fungal Pathogenesis (Heitman J, Mitchell AP, Filler SG Edwards JE, eds pp. 505 526. ASM Press, Washington, DC.
35. Fidel PLJ Sobel JD (1999) Murine models of Candida vaginal infections. Handbook of Animal Models of Infection (Sande M Zak O, eds pp. 741 748. Academic Press, London.
36. Hamad M, Muta'eb E, bu-Shaqra Q, Fraij A, bu-Elteen K Yasin SR (2006) Utility of the oestrogen-dependent vaginal candidosis murine model in evaluating the efficacy of various therapies against vaginal Candida albicans infection. Mycoses 49 : 104 108.
37. Hoyer LL, Green CB, Oh SH Zhao X (2007) Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family - a sticky pursuit. Med Mycol 46 : 1 15.
38. Huang W, Na L, Fidel P Schwarzenberger P (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190 : 624 631.
39. Jones JH Russell C (1973) Experimental oral candidiasis in weanling rats. J Dent Res 52 : 182.
40. Kamai Y, Kubota M, Kamai Y, Hosokawa T, Fukuoka T Filler SG (2001) New model of oropharyngeal candidiasis in mice. Antimicrob Agents Chemother 45 : 3195 3197.
41. Kamai Y, Kubota M, Kamai Y, Hosokawa T, Fukuoka T Filler SG (2002) Contribution of Candida albicans ALS1 to the pathogenesis of experimental oropharyngeal candidiasis. Infect Immun 70 : 5256 5258.
42. Kazmi SH, Naglik JR, Sweet SP, Evans RW, O'Shea S, Banatvala JE Challacombe SJ (2006) Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids. Clin Vaccine Immunol 13 : 1111 1118.
43. Klein RS, Harris CA, Small CB, Moll B, Lesser M Friedland GH (1984) Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. NEJM 311 : 354 358.
44. Kurtzman CP, Robnett CJ, Ward JM, Brayton C, Gorelick P Walsh TJ (2005) Multigene phylogenetic analysis of pathogenic Candida species in the Kazachstania (Arxiozyma) telluris complex and description of their ascosporic states as Kazachstania bovina sp. nov., K. heterogenica sp. nov., K. pintolopesii sp. nov., and K. slooffiae sp. nov. J Clin Microbiol 43 : 101 111.
45. Lacasse M, Fortier C, Chakir J, Cote L Deslauriers N (1993) Acquired resistance and persistence of Candida albicans following oral candidiasis in the mouse: a model of the carrier state in humans. Oral Microbiol Immunol 8 : 313 318.
46. Moen K, Kvalvik AG, Hellem S, Jonsson R Brun JG (2005) The long-term effect of anti TNF-[alpha] treatment on temporomandibular joints, oral mucosa, and salivary flow in patients with active rheumatoid arthritis: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 100 : 433 440.
47. Mukherjee PK, Seshan KR, Leidich SD, Chandra J, Cole GT Ghannoum MA (2001) Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo. Microbiology 147 : 2585 2597.
48. Mylonakis E, Casadevall A Ausubel FM (2007) Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog 3 : e101.
49. Naglik JR, Challacombe SJ Hube B (2003) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67 : 400 428.
50. Netea MG, Sutmuller R, Hermann C, Van Der Graaf CA, Van Der Meer JW, van Krieken JH, Hartung T, Adema G Kullberg BJ (2004) Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 172 : 3712 3718.
51. O'Connor C, Essmann M Larsen B (1998) 17-beta-estradiol upregulates the stress response in Candida albicans: implications for microbial virulence. Infect Dis Obstet Gynecol 6 : 176 181.
52. Ohta H, Tanimoto T, Taniai M, Taniguchi M, Ariyasu T, Arai S, Ohta T Fukuda S (2007) Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis. In Vivo 21 : 25 32.
53. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ Edwards JE (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 38 : 161 189.
54. Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, Welch WH, Ibrahim AS, Edwards JE Filler SG (2007) Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5 : e64.
55. Pope LM, Cole GT, Guentzel MN Berry LJ (1979) Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge. Infect Immun 25 : 702 707.
56. Rahman D Challacombe SJ (1995) Oral immunization against mucosal candidiasis in a mouse model. Adv Exp Med Biol 371B : 1663 1666.
57. Rahman D, Mistry M, Thavaraj S, Challacombe SJ Naglik JR (2007) Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions. Microbes Infect 9 : 615 622.
58. Richard M, Ibata-Ombetta S, Dromer F, Bordon-Pallier F, Jouault T Gaillardin C (2002) Complete glycosylphosphatidylinositol anchors are required in Candida albicans for full morphogenesis, virulence and resistance to macrophages. Mol Microbiol 44 : 841 853.
59. Riggle PJ, Andrutis KA, Chen X, Tzipori SR Kumamoto CA (1999) Invasive lesions containing filamentous forms produced by a Candida albicans mutant that is defective in filamentous growth in culture. Infect Immun 67 : 3649 3652.
60. Saavedra M, Taylor B, Lukacs N Fidel PL Jr. (1999) Local production of chemokines during experimental vaginal candidiasis. Infect Immun 67 : 5820 5826.
61. Samaranayake YH Samaranayake LP (2001) Experimental oral candidiasis in animal models. Clin Microbiol Rev 14 : 398 429.
62. Savage DC Dubos RJ (1967) Localization of indigenous yeast in the murine stomach. J Bacteriol 94 : 1811 1816.
63. Schaller M, Mailhammer R, Grassl G, Sander CA, Hube B Korting HC (2002) Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 118 : 652 657.
64. Schaller M, Boeld U, Oberbauer S, Hamm G, Hube B Korting HC (2004) Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 150 : 2807 2813.
65. Schaller M, Zakikhany K, Naglik JR, Weindl G Hube B (2006) Models of oral and vaginal candidiasis based on in vitro reconstituted human epithelia. Nat Protoc 1 : 2767 2773.
66. Singleton DR, Fidel PL Jr., Wozniak KL Hazen KC (2005) Contribution of cell surface hydrophobicity protein 1 (Csh1p) to virulence of hydrophobic Candida albicans serotype A cells. FEMS Microbiol Lett 244 : 373 377.
67. Skowronski R Feldman D (1989) Characterization of an estrogen-binding protein in the yeast Candida albicans. Endocrinology 124 : 1965 1972.
68. Spearow JL, Doemeny P, Sera R, Leffler R Barkley M (1999) Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science 285 : 1259 1261.
69. Styrt B Sugarman B (1991) Estrogens and infection. Rev Infect Dis 13 : 1139 1150.
70. Tan J, Li J, Chen S, Wu Y, Qin FT, Ding J, Cao F Zhang S (2005) Susceptibility to vaginal candidiasis under different conditions in mice. J Huazhong Univ Sci Technolog Med Sci 25 : 744 746.
71. Taylor BN, Fichtenbaum C, Saavedra M, Slavinsky III, Swoboda R, Wozniak K, Arribas A, Powderly W Fidel JP (2000a) In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus. J Infect Dis 182 : 955 959.
72. Taylor BN, Saavedra M Fidel P Jr. (2000b) Local Th1/Th2 cytokine production during experimental vaginal candidiasis: potential importance of transforming growth factor-beta. Med Mycol 38 : 419 431.
73. Weindl G, Naglik JR, Kaesler S, Biedermann T, Hube B, Korting HC Schaller M (2007) Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest 117 : 3664 3672.
74. Westwater C, Balish E, Warner TF, Nicholas PJ, Paulling EE Schofield DA (2007) Susceptibility of gnotobiotic transgenic mice (Tg{epsilon}26) with combined deficiencies in natural killer cells and T cells to wild-type and hyphal signalling-defective mutants of Candida albicans. J Med Microbiol 56 : 1138 1144.
75. White SJ, Rosenbach A, Lephart P, Nguyen D, Benjamin A, Tzipori S, Whiteway M, Mecsas J Kumamoto CA (2007) Self-regulation of Candida albicans population size during GI colonization. PLoS Pathogen 3 : 1866 1878.
76. Wong B, Brauer KL, Clemens JR Beggs S (1990) Effects of gastrointestinal candidiasis, antibiotics, dietary arabinitol, and cortisone acetate on levels of the Candida metabolite D-arabinitol in rat serum and urine. Infect Immun 58 : 283 288.
77. Wormley FL Jr., Chaiban J Fidel PL Jr. (2001) Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis. Infect Immun 69 : 5072 5079.
78. Yu JJ Gaffen SL (2008) Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 13 : 170 177.
79. Zelante T, De LA, Bonifazi P et al 2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37 : 2695 2706.
80. Zhao XJ, Elhaney-Feser GE, Bowen WH, Cole MF, Broedel SE Jr. Cihlar RL (1996) Requirement for the Candida albicans FAS2 gene for infection in a rat model of oropharyngeal candidiasis. Microbiology 142 : 2509 2514.